Skip to main content

Table 1 Baseline demographic characteristics of the study population

From: Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA)

Variables Total (N = 2402)
Age 60.2 ± 9.6
Male 1767 (73.6%)
Height (cm) 166.9 ± 8.6
Weight (kg) 71.7 ± 12.0
Paroxysmal AF 1097 (45.7%)
Persistent AF 1035 (43.1%)
Hypertension 1218 (50.7%)
Diabetes mellitus 434 (18.1%)
Heart failure 259 (10.8%)
Ischemic stroke/TIA/SE 219 (9.1%)
Ischemic heart disease 178 (7.4%)
Any cardiomyopathies1 93 (3.9%)
Valvular heart diseases 92 (3.8%)
History of cardiac operation 51 (2.1%)
Peripheral arterial disease 19 (0.8%)
Obstructive sleep apnea 112 (4.7%)
Oral anticoagulants
 No 135 (5.6%)
 Warfarin 271 (11.3%)
 DOAC 1996 (83.1%)
Antiplatelet agents
 No 2273 (94.6%)
 Single 121 (5.0%)
 Multiple 8 (0.3%)
LV ejection fraction (%) 59.0 ± 8.5
LA diameter (mm) 43.4 ± 6.7
  1. Categorical data are expressed in frequency (percentage) and continuous data are expressed in mean ± standard deviation
  2. 1Any cardiomyopathies included ischemic cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, amyloidosis, and sarcoidosis
  3. AF, atrial fibrillation; LA, left atrium; LV, left ventricule; DOAC, direct oral anticoagulant; TIA, transient ischemic attack; SE, systemic embolism